LV-FAH

N/A

Report date: 2024/12/13 13:18:32

Base Information

Drug NameLV-FAH
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vector
Mechanisms of ActionFumarylacetoacetase agonists
TargetsFumarylacetoacetase
Therapy Area/IndicationsTyrosinemias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsTyrosinemias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A